In the older population of cancer patients, specific cancer treatments such as new tyrosine kinase-targeting and Vascular endothelial growth factor inhibitor (VEGFi) drugs can lead to hypertension in cancer patients [9, 10]. This evidence concerns the gene VEGFA and cancer.